| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-10 |
| filingDate |
2011-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2013-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-WO2012023600-A1 |
| titleOfInvention |
4-Isopropyl-6-methoxyphenylglucitol compound |
| abstract |
Provided is a compound that inhibits SGLT1 (sodium-dependent glucose cotransporter 1) activity and suppresses absorption of glucose and the like, thereby suppressing glucose intolerance or postprandial hyperglycemia in diabetes. Specifically, a 4-isopropyl-6-methoxyphenyl glucitol compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof is provided. [Chemical 1] |
| priorityDate |
2010-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |